Follow Forum_Psych on Twitter
Search
 
 

Display results as :
 


Rechercher Advanced Search

Statistics
We have 222 registered users
The newest registered user is raheelmemon

Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Share

Switching to Aripiprazole May Reduce Metabolic Risk in patients with Schizophrenia

View previous topic View next topic Go down

Switching to Aripiprazole May Reduce Metabolic Risk in patients with Schizophrenia

Post  Admin on Thu Jun 02, 2011 1:59 pm

May 25, 2011 (Honolulu, Hawaii) — Switching from the atypical antipsychotics olanzapine, quetiapine, or risperidone to the atypical antipsychotic aripiprazole may reduce metabolic risk in patients with schizophrenia, new research suggests.

Scott Stroup, MD, MPH, director of the Program for Intervention Effectiveness Research at Columbia University Medical Center in New York City



"The commonly used antipsychotic medications are associated with metabolic problems that are risk factors for cardiovascular disease [CVD]. And we know that people with schizophrenia are dying prematurely from CVD. So we wanted to try and find solutions to that problem," Dr. Stroup said.

Details here
---> http://www.medscape.com/viewarticle/743435?src=smo_pysch

*****************
Click on to post your comments
avatar
Admin
Admin
Admin

Posts : 948
Points : 2102
Reputation : 0
Join date : 2011-02-19
Location : Philadelphia

http://psychiatry.find-forum.net

Back to top Go down

View previous topic View next topic Back to top

- Similar topics

 
Permissions in this forum:
You cannot reply to topics in this forum